Dioscin ameliorates hyperuricemia-induced atherosclerosis by modulating of cholesterol metabolism through FXR-signaling pathway
The sale of compounds through this website is conducted strictly on a non-medicinal, research-only basis
CagriSema (Cagrilintide + Semaglutide) CagriSema is a co-formulated combination therapy containing 2.4 mg each of Cagrilintide (a long-acting amylin analog) and Semaglutide (a GLP-1 receptor agonist), administered as a single weekly subcutaneous injection
No over-the-counter GLP-1s are available at this time
Clinical trials may differ in patient population, baseline weight and BMI, diabetes status, medication dose, treatment duration, nutrition and lifestyle support, dropout rates, side-effect profiles, study design, and whether the data are published, peer-reviewed, or topline results
The condition causes repeated breathing interruptions during sleep, leading to oxygen desaturation, frequent awakenings, and severely degraded sleep quality